Dr. Jasleen Kukreja is an Associate Professor of Surgery, and Program and Surgical Director of the UCSF Lung Transplant Program. She is a thoracic surgeon who treats patients with tumors of the chest including lung cancer, esophageal cancer, mediastinal tumors, mesothelioma and performs the fully array of thoracic procedures including lung transplantation for patients with lung diseases.
Dr. Kukreja trained at Brigham and Women's Hospital under Dr. David Sugarbaker, and at the Dana Farber Cancer Institute, completing fellowships in both thoracic surgery and thoracic oncology. As a CALGB (Cancer and Leukemia Group B) clinical research fellow, Dr. Kukreja received extensive training in the design of clinical trials.
Dr. Kukreja served as Chief Cardiothoracic Resident at UCSF under Dr. David Jablons, Chief of General Thoracic Surgery. She also studied the techniques of minimally invasive thoracic surgery at Cedars Sinai Medical Center under Dr. Robert McKenna, Jr., Surgical Director of the Center for Chest Diseases.
Dr. Kukreja has authored numerous peer-reviewed articles and lectures on surgery for lung cancer, esophageal cancer and mesothelioma. She is also the recipient of numerous professional honors including the Pharmacia/Upjohn Trauma Research Competition Award, the John A. Mannick Research Award, and Excellence in Teaching Award at the Harvard Medical School.
"UCSF Medical Center is at the forefront of successfully treating patients with end-stage lung disease who have exhausted traditional medical therapies. The UCSF Lung Transplant Program is one of three in the nation with higher-than-expected one-year patient survival rates, even though UCSF transplants some of the most complex patients. The program has performed 468 lung transplants since 1991, and is pioneering new approaches to improve outcomes and make transplantation available to more patients. "Teamwork is critical to the success of our program," said Jasleen Kukreja, M.D., MPH, surgical director of the program. "This includes our pulmonologists, surgical housestaff, operating room staff, anesthesiologists, intensive care unit nursing staff, physical therapists, respiratory therapists and many others." Kukreja and the team perform 40 to 50 lung transplants annually."
"Jimenez went to UCSF's Lung Transplant Program, one of the top programs in the country, according to the latest Scientific Registry of Transplant Recipients. UCSF is among three out of 70 programs for "higher than expected" outcomes based on complex risk factors.
The success of the program is multifactorial and a multidisciplinary effort that starts with excellent anesthetic management, meticulous surgical technique and perioperative surgical care, and long-term close surveillance," said Jasleen Kukreja, MD, MPH, program and surgical director of the UCSF Lung Transplant Program."
Dr. Jasleen Kukreja "is not the first surgeon to perform a minimally invasive lobectomy at UCSF, but she may be a pioneer in the two-finger clamp technique, because her predecessors are men who have a tougher time squeezing in both fingers. Last summer, she became the first doctor to be hired by UCSF to focus primarily on this discipline."